| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2418555
Max Phase: Preclinical
Molecular Formula: C24H24N2O6S
Molecular Weight: 468.53
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCN1C(=O)/C(=C/c2ccc(OCC(=O)OC)cc2)S/C1=N\c1cccc(C(=O)O)c1
Standard InChI: InChI=1S/C24H24N2O6S/c1-3-4-12-26-22(28)20(13-16-8-10-19(11-9-16)32-15-21(27)31-2)33-24(26)25-18-7-5-6-17(14-18)23(29)30/h5-11,13-14H,3-4,12,15H2,1-2H3,(H,29,30)/b20-13-,25-24-
Standard InChI Key: KBWRNRJOXBHSBU-QUSCMMCHSA-N
Associated Targets(non-human)
O-acetylserine sulfhydrylase 237 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 468.53 | Molecular Weight (Monoisotopic): 468.1355 | AlogP: 4.34 | #Rotatable Bonds: 9 |
| Polar Surface Area: 105.50 | Molecular Species: ACID | HBA: 7 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.86 | CX Basic pKa: 2.34 | CX LogP: 4.42 | CX LogD: 1.34 |
| Aromatic Rings: 2 | Heavy Atoms: 33 | QED Weighted: 0.43 | Np Likeness Score: -1.34 |
References
| 1. Poyraz O, Jeankumar VU, Saxena S, Schnell R, Haraldsson M, Yogeeswari P, Sriram D, Schneider G.. (2013) Structure-guided design of novel thiazolidine inhibitors of O-acetyl serine sulfhydrylase from Mycobacterium tuberculosis., 56 (16): [PMID:23879381] [10.1021/jm400710k] |
Source
Source(1):